Literature DB >> 22167068

Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner.

Saverio Bellusci1,2, Parviz Minoo1,3, Caterina Tiozzo1,3,4, Soula Danopoulos1, Maria Lavarreda-Pearce1, Sheryl Baptista1, Radka Varimezova1, Denise Al Alam1, David Warburton1, Rehan Virender5, Stijn De Langhe6, Antonio Di Cristofano7.   

Abstract

Even though the role of the tyrosine phosphatase Pten as a tumor suppressor gene has been well established in thyroid cancer, its role during thyroid development is still elusive. We therefore targeted Pten deletion in the thyroid epithelium by crossing Pten(flox/flox) with a newly developed Nkx2.1-cre driver line in the BALB/c and C57BL/6 genetic backgrounds. C57BL/6 homozygous Pten mutant mice died around 2 weeks of age due to tracheal and esophageal compression by a hyperplasic thyroid. By contrast, BALB/c homozygous Pten mutant mice survived up to 2 years, but with a slightly increased thyroid volume. Characterization of the thyroid glands from C57BL/6 homozygous Pten mutant mice at postnatal day 14 (PN14) showed abnormally enlarged tissue with areas of cellular hyperplasia, disruption of the normal architecture, and follicular degeneration. In addition, differing degrees of hypothyroidism, thyroxine (T(4)) decrease, and thyroid-stimulating hormone elevation between the strains in the mutants and the heterozygous mutant were detected at PN14. Finally, C57BL/6 heterozygous Pten mutant mice developed thyroid tumors after 2 years of age. Our results indicate that Pten has a pivotal role in thyroid development and its deletion results in thyroid tumor formation, with the timing and severity of the tumor depending on the particular genetic background.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22167068      PMCID: PMC4217534          DOI: 10.1530/ERC-10-0327

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  23 in total

1.  Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

Authors:  Ralf Lesche; Matthias Groszer; Jing Gao; Ying Wang; Albee Messing; Hong Sun; Xin Liu; Hong Wu
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

Review 2.  Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors.

Authors:  J E Dumont; F Lamy; P Roger; C Maenhaut
Journal:  Physiol Rev       Date:  1992-07       Impact factor: 37.312

3.  Overexpression and overactivation of Akt in thyroid carcinoma.

Authors:  M D Ringel; N Hayre; J Saito; B Saunier; F Schuppert; H Burch; V Bernet; K D Burman; L D Kohn; M Saji
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

4.  Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin.

Authors:  K Coulonval; F Vandeput; R C Stein; S C Kozma; F Lamy; J E Dumont
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

Review 5.  Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models.

Authors:  T Kimura; A Van Keymeulen; J Golstein; A Fusco; J E Dumont; P P Roger
Journal:  Endocr Rev       Date:  2001-10       Impact factor: 19.871

6.  Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation.

Authors:  G Brabant; C Maenhaut; J Köhrle; G Scheumann; H Dralle; C Hoang-Vu; R D Hesch; A von zur Mühlen; G Vassart; J E Dumont
Journal:  Mol Cell Endocrinol       Date:  1991-11       Impact factor: 4.102

7.  Thyroid incidentalomas. Prevalence by palpation and ultrasonography.

Authors:  S Ezzat; D A Sarti; D R Cain; G D Braunstein
Journal:  Arch Intern Med       Date:  1994-08-22

8.  Thyrocyte-specific expression of Cre recombinase in transgenic mice.

Authors:  Takashi Kusakabe; Akio Kawaguchi; Rumi Kawaguchi; Lionel Feigenbaum; Shioko Kimura
Journal:  Genesis       Date:  2004-07       Impact factor: 2.487

9.  In vivo characterization of the Nkx2.1 promoter/enhancer elements in transgenic mice.

Authors:  Qiuping Pan; Changgong Li; Jing Xiao; Shioko Kimura; John Rubenstein; Luis Puelles; Parviz Minoo
Journal:  Gene       Date:  2004-04-28       Impact factor: 3.688

10.  TSH-activated signaling pathways in thyroid tumorigenesis.

Authors:  Marcos Rivas; Pilar Santisteban
Journal:  Mol Cell Endocrinol       Date:  2003-12-31       Impact factor: 4.102

View more
  6 in total

1.  Thyroid-Specific PPARγ Deletion Is Benign in the Mouse.

Authors:  Jingcheng Yu; Ronald J Koenig
Journal:  Endocrinology       Date:  2018-03-01       Impact factor: 4.736

Review 2.  Mouse models of thyroid cancer: A 2015 update.

Authors:  Lawrence S Kirschner; Zahida Qamri; Suresh Kari; Amruta Ashtekar
Journal:  Mol Cell Endocrinol       Date:  2015-06-27       Impact factor: 4.102

3.  Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.

Authors:  Shuyun Rao; Kathy Q Cai; Jason E Stadanlick; Noa Greenberg-Kushnir; Nehal Solanki-Patel; Sang-Yun Lee; Shawn P Fahl; Joseph R Testa; David L Wiest
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

4.  Genome-wide association mapping of acute lung injury in neonatal inbred mice.

Authors:  Jennifer L Nichols; Wesley Gladwell; Kirsten C Verhein; Hye-Youn Cho; Jürgen Wess; Oscar Suzuki; Tim Wiltshire; Steven R Kleeberger
Journal:  FASEB J       Date:  2014-02-26       Impact factor: 5.191

5.  Reduced NKX2.1 expression predicts poor prognosis of gastric carcinoma.

Authors:  Bai-Wei Zhao; Shan-Shan Jiang; Yong-Ming Chen; Chun-Yu Huang; Yuan-Fang Li
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

6.  PTEN-knockdown disrupts the morphology, growth pattern and function of Nthy-Ori 3-1 cells by downregulating PAX8 expression.

Authors:  Zhuo Sun; Jinqi Lu; Muyu Wu; Changli Ouyang; Yueping Xing; Xiancun Hou; Zhenduo Shi; Yongping Wu
Journal:  Oncol Lett       Date:  2019-10-31       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.